KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Goodwill & Intangibles (2018 - 2025)

Vir Biotechnology's Goodwill & Intangibles history spans 8 years, with the latest figure at $24.8 million for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 1.23% to $24.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.8 million, a 1.23% decrease, with the full-year FY2025 number at $24.8 million, down 1.23% from a year prior.
  • Goodwill & Intangibles hit $24.8 million in Q4 2025 for Vir Biotechnology, roughly flat from $24.9 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for VIR hit a ceiling of $50.6 million in Q1 2021 and a floor of $24.8 million in Q4 2025.
  • Historically, Goodwill & Intangibles has averaged $40.6 million across 5 years, with a median of $42.5 million in 2023.
  • Biggest five-year swings in Goodwill & Intangibles: surged 163.14% in 2021 and later tumbled 36.57% in 2024.
  • Tracing VIR's Goodwill & Intangibles over 5 years: stood at $50.2 million in 2021, then dropped by 1.06% to $49.7 million in 2022, then dropped by 20.51% to $39.5 million in 2023, then crashed by 36.57% to $25.1 million in 2024, then decreased by 1.23% to $24.8 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for VIR at $24.8 million in Q4 2025, $24.9 million in Q3 2025, and $24.9 million in Q2 2025.